Elanco Animal Health
Elanco Animal Health Inc is a global animal health enterprise headquartered in Greenfield, Indiana. The company develops, manufactures, and markets veterinary medicines, vaccines, parasiticides, and nutritional health products for livestock and companion animals. Its product lineup supports cattle, swine, poultry, aquaculture, dogs, and cats by preventing and treating various animal diseases. Principal revenue is derived from wholesale product sales to veterinary clinics, agricultural producers, and animal distribution networks worldwide. The enterprise operates research centers and manufacturing facilities across multiple international regions. Elanco Animal Health Inc is publicly listed on the New York Stock Exchange.
11 of the funds FundTelligence covers report a position in Elanco Animal Health.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 11
- Exposure themes
- Agricultural Technology & Inputs, Food & Agriculture Transformation, Inputs & Biologicals
Funds holding Elanco Animal Health
- T. Rowe Price US Smaller Companies Equity Fund — T. Rowe Price · 1.41 % (full portfolio disclosed, September 2026)
- Schroder ISF Healthcare Innovation — Schroders · 1.34 % (full portfolio disclosed, June 2026)
- Nordea Global High Yield Sustainable Stars Bond Fund — Nordea Funds · 0.27 % (full portfolio disclosed, September 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.24 % (full portfolio disclosed, September 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.22 % (full portfolio disclosed, December 2025)
- Alfred Berg Global High Yield — Alfred Berg · 0.14 % (full portfolio disclosed, June 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.12 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.11 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 11 funds holding it.